HI

Health In Tech, Inc.

HIT·NASDAQ

$0.96

-4.9%
TechnologySoftware - Application

Health In Tech, Inc. operates as an insurance technology platform company. The company offers reference-based pricing, group insurance captives, community health plans, and association health programs for small businesses; and enhance do it yourself benefit system (eDIYBS), a web-based SaaS quoting platform to quote health insurance for small to medium sized employers. It also provides health intelligence (HI) card to streamline the management of medical records and claims; and HI performance network, which offers a series of hospital facilities, as well as delivers medicare-based reimbursement pricing. Health In Tech, Inc. was founded in 2014 and is headquartered in Stuart, Florida.

At a Glance

Live Snapshot
Market Cap$51.96M
EPS0.0200
P/E Ratio48.25
Earnings Date07/20/2026
h

Health In Tech, Inc. Street Expectations Map

HIT · NASDAQ

Wall Street analysts project that HIT stock may rise significantly over the coming 12 months. The consensus 1-year price target stands at 4.00, with estimates ranging from a low of 4.00 to a high of 4.00.

Lowest Target
4.00
314.51%
Consensus Target
4.00
314.51%
Highest Target
4.00
314.51%

The consensus 1-year price target stands at 4.00, with estimates ranging from a low of 4.00 to a high of 4.00.

Analyst Consensus Analysis

Upside Potential

+314.5%

Substantial upside potential. Analysts see significant value gap, suggesting the stock may be materially undervalued at current levels.

Analyst Agreement

0.0% spread

High analyst agreement. Narrow target range indicates strong consensus on valuation, suggesting clear investment thesis and predictable outlook.

Analyst Conviction

Very High

Strong buy conviction: High upside with tight consensus suggests compelling investment opportunity backed by analyst confidence.

Market Sentiment Insight

Rare opportunity: Exceptional upside potential with strong analyst consensus creates a compelling setup. The combination of significant price target premium and tight agreement suggests high-conviction undervaluation that may attract institutional capital.

h

Health In Tech, Inc. Forward Estimates of Revenue

HIT · NASDAQ
Latest Revenue
33.33M
FY 2025
Avg Estimate
46.83M
FY 2026
Estimate Range
46.47M - 47.31M
Analyst Spread

Forward Growth Analysis

Projected Growth+40.5%

Strong growth expectations signal robust business momentum and market opportunity expansion.

Analyst Coverage2 Analysts

Limited coverage may indicate reduced institutional interest or information availability.

Estimate Spread2%

Narrow estimate range signals strong analyst consensus and predictable business outlook.

OutlookPositive

Generally favorable outlook with reasonable growth prospects and analyst support.

Key Insight

Compelling growth story with analyst consensus: Strong projected growth combined with narrow estimate spread suggests high-conviction opportunity.

h

Health In Tech, Inc. Forward Estimates of Net Income

HIT · NASDAQ
Latest Net Income
1.28M
FY 2025
Avg Estimate
-3.28M
FY 2026
Estimate Range
-3.32M - -3.24M
Analyst Spread

Forward Growth Analysis

Projected Growth-356.3%

Significant contraction projected—major business challenges or industry disruption likely.

Analyst Coverage2 Analysts

Limited coverage may indicate reduced institutional interest or information availability.

Estimate Spread2%

Narrow estimate range signals strong analyst consensus and predictable business outlook.

OutlookNeutral

Mixed signals—some positive indicators offset by concerns about growth or uncertainty.

Key Insight

Limited coverage with volatile estimates: Few analysts covering despite significant projected changes may indicate information gaps or emerging risks.

h

Health In Tech, Inc. Forward Estimates of EPS

HIT · NASDAQ
Latest EPS
0.02
FY 2025
Avg Estimate
$-0.06
FY 2026
Estimate Range
$-0.06 - $-0.06
Analyst Spread

Forward Growth Analysis

Projected Growth-383.3%

Significant contraction projected—major business challenges or industry disruption likely.

Analyst Coverage2 Analysts

Limited coverage may indicate reduced institutional interest or information availability.

Estimate Spread2%

Narrow estimate range signals strong analyst consensus and predictable business outlook.

OutlookNeutral

Mixed signals—some positive indicators offset by concerns about growth or uncertainty.

Key Insight

Limited coverage with volatile estimates: Few analysts covering despite significant projected changes may indicate information gaps or emerging risks.

h

Health In Tech, Inc. Forward Estimates of EBIT

HIT · NASDAQ
Latest EBIT
1.67M
FY 2025
Avg Estimate
3.93M
FY 2026
Estimate Range
3.90M - 3.97M
Analyst Spread

Forward Growth Analysis

Projected Growth+134.7%

Strong growth expectations signal robust business momentum and market opportunity expansion.

Analyst Coverage2 Analysts

Limited coverage may indicate reduced institutional interest or information availability.

Estimate Spread2%

Narrow estimate range signals strong analyst consensus and predictable business outlook.

OutlookPositive

Generally favorable outlook with reasonable growth prospects and analyst support.

Key Insight

Compelling growth story with analyst consensus: Strong projected growth combined with narrow estimate spread suggests high-conviction opportunity.

h

Health In Tech, Inc. Forward Estimates of EBITDA

HIT · NASDAQ
Latest EBITDA
2.57M
FY 2025
Avg Estimate
4.78M
FY 2026
Estimate Range
4.74M - 4.83M
Analyst Spread

Forward Growth Analysis

Projected Growth+85.6%

Strong growth expectations signal robust business momentum and market opportunity expansion.

Analyst Coverage2 Analysts

Limited coverage may indicate reduced institutional interest or information availability.

Estimate Spread2%

Narrow estimate range signals strong analyst consensus and predictable business outlook.

OutlookPositive

Generally favorable outlook with reasonable growth prospects and analyst support.

Key Insight

Compelling growth story with analyst consensus: Strong projected growth combined with narrow estimate spread suggests high-conviction opportunity.

h

Health In Tech, Inc. Forward Estimates of SG&A Expense

HIT · NASDAQ
Latest SG&A Expense
17.84M
FY 2025
Avg Estimate
29.26M
FY 2026
Estimate Range
29.04M - 29.56M
Analyst Spread

Forward Growth Analysis

Projected Growth+64.0%

Strong growth expectations signal robust business momentum and market opportunity expansion.

Analyst Coverage2 Analysts

Limited coverage may indicate reduced institutional interest or information availability.

Estimate Spread2%

Narrow estimate range signals strong analyst consensus and predictable business outlook.

OutlookPositive

Generally favorable outlook with reasonable growth prospects and analyst support.

Key Insight

Compelling growth story with analyst consensus: Strong projected growth combined with narrow estimate spread suggests high-conviction opportunity.

h

Health In Tech, Inc. Insider Positioning

HIT · NASDAQ

During the last 12 months, insiders have purchased $379K worth of HIT shares, with no selling activity reported.

3 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

3-6 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

6-9 Months

Bought

17.2K

59.99K

Sold

0

0.00

Net Activity

+60K

+$60K

9-12 Months

Bought

513.9K

318.61K

Sold

0

0.00

Net Activity

+319K

+$319K

Top Buyers

1
HWD

Howard William D.

Director

134.2K shares2 transactions

$100K

2
HT

Hayes Timothy

Director

134.2K shares2 transactions

$100K

3
SSK

Shrestha Sanjay K

Director

134.2K shares2 transactions

$100K

4
UC

Umemezia Chike

Director

128.5K shares1 transactions

$80K

Top Sellers

No selling activity

Insider Activity Analysis

Net Insider Sentiment

Bullish

Strong bullish signal with $379K net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.

Buy/Sell Ratio

∞:1

Perfect buy/sell ratio. Only buying activity with zero selling—the most bullish possible insider signal.

Insider Participation

High Buying

4 insider buyers vs. 0 sellers. Broad-based buying across management team suggests widespread confidence.

Insider Activity Insight

Compelling insider conviction: The combination of strong buy/sell ratio and multiple buyers suggests insiders see attractive risk/reward. Consider this alongside fundamental analysis for confirmation.